- Home
- XBP vs ACXP Comparison
XBP vs ACXP Comparison
Compare XBP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- ACXP
- Stock Information
- Founded
- XBP 2020
- ACXP 2017
- Country
- XBP United States
- ACXP United States
- Employees
- XBP N/A
- ACXP N/A
- Industry
- XBP Business Services
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- ACXP Health Care
- Exchange
- XBP Nasdaq
- ACXP Nasdaq
- Market Cap
- XBP 71.0M
- ACXP 6.8M
- IPO Year
- XBP N/A
- ACXP 2021
- Fundamental
- Price
- XBP $0.98
- ACXP $4.17
- Analyst Decision
- XBP
- ACXP Strong Buy
- Analyst Count
- XBP 0
- ACXP 3
- Target Price
- XBP N/A
- ACXP $143.67
- AVG Volume (30 Days)
- XBP 502.8K
- ACXP 70.5K
- Earning Date
- XBP 11-11-2025
- ACXP 11-12-2025
- Dividend Yield
- XBP N/A
- ACXP N/A
- EPS Growth
- XBP N/A
- ACXP N/A
- EPS
- XBP N/A
- ACXP N/A
- Revenue
- XBP $148,332,000.00
- ACXP N/A
- Revenue This Year
- XBP N/A
- ACXP N/A
- Revenue Next Year
- XBP N/A
- ACXP N/A
- P/E Ratio
- XBP N/A
- ACXP N/A
- Revenue Growth
- XBP 0.23
- ACXP N/A
- 52 Week Low
- XBP $0.42
- ACXP $3.80
- 52 Week High
- XBP $2.56
- ACXP $44.00
- Technical
- Relative Strength Index (RSI)
- XBP 67.40
- ACXP 37.31
- Support Level
- XBP $0.65
- ACXP $4.02
- Resistance Level
- XBP $1.01
- ACXP $4.34
- Average True Range (ATR)
- XBP 0.10
- ACXP 0.49
- MACD
- XBP 0.05
- ACXP 0.10
- Stochastic Oscillator
- XBP 93.13
- ACXP 10.24
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.